PRKN and Parkinson disease: For the common neurodegenerative disease PD, the activity of PD complex I decreased due to overexpression of α-synuclein and inhibition of rotenone inhibitory complex I, the activity of mitochondrial kinase PINK1 with protective cell function decreased, and Parkin mutation [86] and other factors damaged mitochondrial function and promoted the occurrence of PD.